62 related articles for article (PubMed ID: 19781607)
1. Wistar rat skin as surrogate for human skin in nortriptyline hydrochloride patch studies.
Melero A; Lehr CM; Schäfer UF; Garrigues TM
Int J Pharm; 2010 Jan; 384(1-2):137-9. PubMed ID: 19781607
[TBL] [Abstract][Full Text] [Related]
2. Nortriptyline for smoking cessation: release and human skin diffusion from patches.
Melero A; Garrigues TM; Alós M; Kostka KH; Lehr CM; Schaefer UF
Int J Pharm; 2009 Aug; 378(1-2):101-7. PubMed ID: 19501148
[TBL] [Abstract][Full Text] [Related]
3. Nortriptyline hydrochloride skin absorption: development of a transdermal patch.
Melero A; Garrigues TM; Almudever P; Villodre AM; Lehr CM; Schäfer U
Eur J Pharm Biopharm; 2008 Jun; 69(2):588-96. PubMed ID: 18191555
[TBL] [Abstract][Full Text] [Related]
4. Enhancement of nortriptyline penetration through human epidermis: influence of chemical enhancers and iontophoresis.
Merino V; Micó-Albiñana T; Nácher A; Díez-Sales O; Herráez M; Merino-Sanjuán M
J Pharm Pharmacol; 2008 Apr; 60(4):415-20. PubMed ID: 18380912
[TBL] [Abstract][Full Text] [Related]
5. Efficacy and irritancy of enhancers on the in-vitro and in-vivo percutaneous absorption of curcumin.
Fang JY; Hung CF; Chiu HC; Wang JJ; Chan TF
J Pharm Pharmacol; 2003 May; 55(5):593-601. PubMed ID: 12831501
[TBL] [Abstract][Full Text] [Related]
6. Effect of the solvent system on the in vitro permeability of nicardipine hydrochloride through excised rat epidermis.
Krishnaiah YS; Satyanarayana V; Karthikeyan RS
J Pharm Pharm Sci; 2002; 5(2):123-30. PubMed ID: 12207864
[TBL] [Abstract][Full Text] [Related]
7. Effect of chemical enhancers on percutaneous absorption of daphnetin in isopropyl myristate vehicle across rat skin in vitro.
Wen Z; Fang L; He Z
Drug Deliv; 2009 May; 16(4):214-23. PubMed ID: 19280376
[TBL] [Abstract][Full Text] [Related]
8. Effect of penetration enhancers on the release and skin permeation of bupranolol from reservoir-type transdermal delivery systems.
Babu RJ; Pandit JK
Int J Pharm; 2005 Jan; 288(2):325-34. PubMed ID: 15620873
[TBL] [Abstract][Full Text] [Related]
9. Design and in vivo evaluation of an indapamide transdermal patch.
Ren C; Fang L; Ling L; Wang Q; Liu S; Zhao L; He Z
Int J Pharm; 2009 Mar; 370(1-2):129-35. PubMed ID: 19114099
[TBL] [Abstract][Full Text] [Related]
10. Discovery of transdermal penetration enhancers by high-throughput screening.
Karande P; Jain A; Mitragotri S
Nat Biotechnol; 2004 Feb; 22(2):192-7. PubMed ID: 14704682
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of in-vivo animal and in-vitro models for prediction of dermal absorption in man.
Jakasa I; Kezic S
Hum Exp Toxicol; 2008 Apr; 27(4):281-8. PubMed ID: 18684798
[TBL] [Abstract][Full Text] [Related]
12. Alteration of skin hydration and its barrier function by vehicle and permeation enhancers: a study using TGA, FTIR, TEWL and drug permeation as markers.
Shah DK; Khandavilli S; Panchagnula R
Methods Find Exp Clin Pharmacol; 2008 Sep; 30(7):499-512. PubMed ID: 18985178
[TBL] [Abstract][Full Text] [Related]
13. Effect of chemical enhancers on the in vitro percutaneous absorption of sumatriptan succinate.
Femenía-Font A; Balaguer-Fernández C; Merino V; Rodilla V; López-Castellano A
Eur J Pharm Biopharm; 2005 Sep; 61(1-2):50-5. PubMed ID: 15925502
[TBL] [Abstract][Full Text] [Related]
14. Effect of O-acylmenthol on transdermal delivery of drugs with different lipophilicity.
Zhao L; Fang L; Xu Y; Zhao Y; He Z
Int J Pharm; 2008 Mar; 352(1-2):92-103. PubMed ID: 18053661
[TBL] [Abstract][Full Text] [Related]
15. The transdermal drug delivery system and transcutaneous absorption.
Morimoto Y; Sugibayashi K; Natsume H
Acta Derm Venereol Suppl (Stockh); 1994; 185():15-7. PubMed ID: 8091920
[No Abstract] [Full Text] [Related]
16. Effect of penetration enhancers on skin permeation of trazodone hydrochloride from matrix type transdermal formulation through mouse and human cadaver epidermis.
Das MK; Bhattacharya A; Ghosal SK
Acta Pol Pharm; 2006; 63(6):535-41. PubMed ID: 17438871
[TBL] [Abstract][Full Text] [Related]
17. Formulation development of transdermal dosage forms: quantitative structure-activity relationship model for predicting activities of terpenes that enhance drug penetration through human skin.
Kang L; Yap CW; Lim PF; Chen YZ; Ho PC; Chan YW; Wong GP; Chan SY
J Control Release; 2007 Jul; 120(3):211-9. PubMed ID: 17582639
[TBL] [Abstract][Full Text] [Related]
18. Combination strategies for enhancing transdermal absorption of sumatriptan through skin.
Femenía-Font A; Balaguer-Fernández C; Merino V; López-Castellano A
Int J Pharm; 2006 Oct; 323(1-2):125-30. PubMed ID: 16809010
[TBL] [Abstract][Full Text] [Related]
19. Transdermal delivery system for zidovudine: in vitro, ex vivo and in vivo evaluation.
Narishetty ST; Panchagnula R
Biopharm Drug Dispos; 2004 Jan; 25(1):9-20. PubMed ID: 14716748
[TBL] [Abstract][Full Text] [Related]
20. Transdermal skin delivery: predictions for humans from in vivo, ex vivo and animal models.
Godin B; Touitou E
Adv Drug Deliv Rev; 2007 Sep; 59(11):1152-61. PubMed ID: 17889400
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
